Human germline genome editing with CRISPR–Cas9 was used with high efficiency, accuracy and safety to correct a heterozygous, autosomal dominant mutation in MYBPC3 associated with hypertrophic cardiomyopathy, according to a new study in Nature.CRISPR–Cas9 is a versatile tool for recognizing a specific

中文翻译：

---

基因疗法：心脏病中的人类基因组编辑

根据Nature上的一项新研究，使用CRISPR–Cas9进行人类种系基因组编辑可高效，准确和安全地纠正与肥厚型心肌病相关的MYBPC3中的杂合性，常染色体显性突变。具体的